Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether the combination of pembrolizumab and
gemcitabine is an effective treatment for mycosis fungoides and Sézary syndrome.